South Korea
· Delayed Price · Currency is KRW SCL Science Company Description
SCL Science Inc., engages in the development and sale of medical sealant products in South Korea.
The company’s products include InnoSEAL, an externally applied hemostatic agent; InnoSEAL Plus, an absorbable hemostatic pad; EndoSil, an absorbable hemostatic agent used for the gastrointestinal oozing bleeding; GellySil, a biomaterial and the proprietary material product.
It also provides Film-type surgical sealant to complete sealing of anastomosis site; STOP needle, a self-sealing needle for general and ophthalmic use; wound dressing used for chronic wounds, burns, etc.; and Gene therapy, a bio-therapeutics delivery system.
The company was formerly known as InnoTherapy, Inc. and changed its name to SCL Science Inc. in March 2024.
SCL Science Inc. was founded in 2010 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 2010 |
| Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
| Employees | 44 |
| CEO | Moon Lee |
Contact Details
Address: #401, ACE Hitech City 2 Seoul, 07282 South Korea | |
| Phone | 82 2 6959 1338 |
| Website | innotherapy.com |
Stock Details
| Ticker Symbol | 246960 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Moon Lee | Chief Executive Officer |
| In Moon | Chief Operating Officer |